Add Company
Join Now

KeViRx Revenue and Competitors

License our Company Data API

Charlottesville, VA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • KeViRx's estimated annual revenue is currently $930k per year.(i)
  • KeViRx's estimated revenue per employee is $155,000

Employee Data

  • KeViRx has 6 Employees.(i)
  • KeViRx grew their employee count by 20% last year.

KeViRx's People

NameTitleEmail/Phone
1
Chief Scientific OfficerReveal Email/Phone
2
Chief Scientific OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3M393%$28.3MN/A
#2
$1.4M9-18%N/AN/A
#3
$5.3M343%N/AN/A
#4
$31.9M2060%N/AN/A
#5
$0.6M4-43%N/AN/A
#6
$4.3M55-52%$56.5MN/A
#7
$0.3M20%N/AN/A
#8
$5.4M3521%N/AN/A
#9
$1.9M120%N/AN/A
#10
$2.6M34-11%$9.8MN/A
Add Company

What Is KeViRx?

KeViRx, Inc. is a preclinical stage pharmaceutical company headquartered in Charlottesville, VA. We are developing small molecules drugs that treat microvascular leakage and inflammation, pathologies that are the basis for many diseases, including cancer and respiratory disease. We are now entering IND-enabling studies for pulmonary microvascular leakage and inflammation during acute lung injury. \n\nOur lead asset, KVX-053 has potent anti-inflammatory and immunomodulatory effects. In preclinical models, KVX-053 reduces lung injury scoring & the biomarkers of lung injury, inflammation & proinflammatory cytokine release, & immune cell infiltration into the lung. KVX-053 also improves lung function after lung injury.\n\nContact us for more information at [email protected].

keywords:N/A

N/A

Total Funding

6

Number of Employees

$930k

Revenue (est)

20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M650%N/A
#2
$0.8M60%N/A
#3
$0.4M620%N/A
#4
$0.4M6-14%N/A
#5
$0.5M70%N/A